Adrenergic chromaffin cells are adrenergic even in the absence of epinephrine.


Journal

Journal of neurochemistry
ISSN: 1471-4159
Titre abrégé: J Neurochem
Pays: England
ID NLM: 2985190R

Informations de publication

Date de publication:
02 2020
Historique:
received: 03 09 2019
revised: 24 10 2019
accepted: 29 10 2019
pubmed: 5 11 2019
medline: 1 7 2020
entrez: 3 11 2019
Statut: ppublish

Résumé

Adrenal chromaffin cells release epinephrine (EPI) and norepinephrine (NE) into the bloodstream as part of the homeostatic response to situations like stress. Here we utilized EPI-deficient mice generated by knocking out (KO) the phenylethanolamine N-methyltransferase (Pnmt) gene. These Pnmt-KO mice were bred to homozygosis but displayed no major phenotype. The lack of EPI was partially compensated by an increase in NE, suggesting that EPI storage was optimized in adrenergic cells. Electron microscopy showed that despite the lack of EPI, chromaffin granules retain their shape and general appearance. This indicate that granules from adrenergic or noradrenergic cells preserve their characteristics even though they contain only NE. Acute insulin injection largely reduced the EPI content in wild-type animals, with a minimal reduction in NE, whereas there was only a partial reduction in NE content in Pnmt-KO mice. The analysis of exocytosis by amperometry revealed a reduction in the quantum size (-30%) and I

Identifiants

pubmed: 31677273
doi: 10.1111/jnc.14904
doi:

Substances chimiques

Phenylethanolamine N-Methyltransferase EC 2.1.1.28
Norepinephrine X4W3ENH1CV
Epinephrine YKH834O4BH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-314

Informations de copyright

© 2019 International Society for Neurochemistry.

Références

Bao X., Liu F., Gu Y., Lu C. M. and Ziegler M. G. (2008) Impaired chronotropic response to exercise in mice lacking catecholamines in adrenergic cells. Ann. N. Y. Acad. Sci. 1148, 297-301.
Baraibar A. M., de Pascual R., Camacho M., Dominguez N., David Machado J., Gandia L. and Borges R. (2018) Distinct patterns of exocytosis elicited by Ca(2+), Sr(2+) and Ba(2+) in bovine chromaffin cells. Pflugers Arch. 470, 1459-1471.
Borg W. P., During M. J., Sherwin R. S., Borg M. A., Brines M. L. and Shulman G. I. (1994) Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J. Clin. Invest. 93, 1677-1682.
Borges R. (1994) Histamine H1 receptor activation mediates the preferential release of adrenaline in the rat adrenal gland. Life Sci. 54, 631-640.
Borges R., Sala F. and Garcia A. G. (1986) Continuous monitoring of catecholamine release from perfused cat adrenals. J. Neurosci. Methods 16, 289-300.
Colliver T. L., Hess E. J. and Ewing A. G. (2001) Amperometric analysis of exocytosis at chromaffin cells from genetically distinct mice. J. Neurosci. Methods 105, 95-103.
Coupland R. E. and Hopwood D. (1966a) Mechanism of a histochemical reaction differentiating between adrenaline- and noradrenaline-storing cells in the electron microscope. Nature 209, 590-591.
Coupland R. E. and Hopwood D. (1966b) The mechanism of the differential staining reaction for adrenaline-and noreadrenaline-storing granules in tissues fixed in glutaraldehyde. J. Anat. 100, 227-243.
Coupland R. E., Kobayashi S. and Crowe J. (1976) On the fixation of catecholamines including adrenaline in tissue sections. J. Anat. 122, 403-413.
Diaz-Flores L., Gutierrez R., Varela H., Valladares F., Alvarez-Arguelles H. and Borges R. (2008) Histogenesis and morphofunctional characteristics of chromaffin cells. Acta Physiol. (Oxf) 192, 145-163.
Diaz-Vera J., Morales Y. G., Hernandez-Fernaud J. R., Camacho M., Montesinos M. S., Calegari F., Huttner W. B., Borges R. and Machado J. D. (2010) Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles. J. Neurosci. 30, 950-957.
Dominguez N., Rodriguez M., Machado J. D. and Borges R. (2012) Preparation and culture of adrenal chromaffin cells. Methods Mol. Biol. 846, 223-234.
Douglas W. W. and Poisner A. M. (1965) Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine. Nature 208, 1102-1103.
Ebert S. N., Rong Q., Boe S., Thompson R. P., Grinberg A. and Pfeifer K. (2004) Targeted insertion of the Cre-recombinase gene at the phenylethanolamine n-methyltransferase locus: a new model for studying the developmental distribution of adrenergic cells. Dev. Dyn. 231, 849-858.
Erickson J. D., Schafer M. K., Bonner T. I., Eiden L. E. and Weihe E. (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl Acad. Sci. USA 93, 5166-5171.
Feuerstein G. and Gutman Y. (1971) Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli. Br. J. Pharmacol. 43, 764-775.
Holzbauer M. and Sharman D. F. (1972) The distribution of catecholamines in vertebrates, in Catecholamines (Blaschko H. and Muscholl E., eds.), pp. 110-185. Springer-Verlag, Berlin.
Koval L. M., Yavorskaya E. N. and Lukyanetz E. A. (2001) Electron microscopic evidence for multiple types of secretory vesicles in bovine chromaffin cells. Gen. Comp. Endocrinol. 121, 261-277.
Machado J. D., Gomez J. F., Betancor G., Camacho M., Brioso M. A. and Borges R. (2002) Hydralazine reduces the quantal size of secretory events by displacement of catecholamines from adrenomedullary chromaffin secretory vesicles. Circ. Res. 91, 830-836.
Machado J. D., Montesinos M. S. and Borges R. (2008) Good practices in single cell amperometry. Methods Mol. Biol. 440, 297-313.
Mahata S. K., Mahata M., Fischer-Colbrie R. and Winkler H. (1993) Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla. Neurosci. Lett. 156, 70-72.
Montesinos M. S., Machado J. D., Camacho M. et al. (2008) The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse. J. Neurosci. 28, 3350-3358.
Montesinos M. S., Camacho M., Machado J. D., Viveros O. H., Beltran B. and Borges R. (2010) The quantal secretion of catecholamines is impaired by the accumulation of beta-adrenoceptor antagonists into chromaffin cell vesicles. Br. J. Pharmacol. 159, 1548-1556.
Moreira-Rodrigues M., Graca A. L., Ferreira M. et al. (2014) Attenuated aortic vasodilation and sympathetic prejunctional facilitation in epinephrine-deficient mice: selective impairment of beta2-adrenoceptor responses. J. Pharmacol. Exp. Ther. 351, 243-249.
Morrison S. F. and Cao W. H. (2000) Different adrenal sympathetic preganglionic neurons regulate epinephrine and norepinephrine secretion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1763-1775.
Nagatsu I., Karasawa N., Kondo Y. and Inagaki S. (1979) Immunocytochemical localization of tyrosine hydroxylase, dopamine-beta-hydroxylase and phenylethanolamine-N-methyltransferase in the adrenal glands of the frog and rat by a peroxidase-antiperoxidase method. Histochemistry 64, 131-144.
Ogata T. and Ogata A. (1917) Henle's reaction of the chromaffin cells in the adrenals, and the microscopic test for adrenalin. J. Exp. Med. 25, 807-817.
Pardo M. R., Estevez-Herrera J., Castaneyra L., Borges R. and Machado J. D. (2017) Isolation of mouse chromaffin secretory vesicles and their division into 12 fractions. Anal. Biochem. 536, 1-7.
Pasqua T., Mahata S., Bandyopadhyay G. K., Biswas A., Perkins G. A., Sinha-Hikim A. P., Goldstein D. S., Eiden L. E. and Mahata S. K. (2016) Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo. Cell Tissue Res. 363, 693-712.
Przywara D. A., Guo X., Angelilli M. L., Wakade T. D. and Wakade A. R. (1996) A non-cholinergic transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells. J. Biol. Chem. 271, 10545-10550.
Sambrook J., Fritsch E. and Maniatis T. (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, NY.
Schindelin J., Arganda-Carreras I., Frise E. et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682.
Schroeder T. J., Borges R., Finnegan J. M., Pihel K., Amatore C. and Wightman R. M. (1996) Temporally resolved, independent stages of individual exocytotic secretion events. Biophys. J. 70, 1061-1068.
Segura F., Brioso M. A., Gomez J. F., Machado J. D. and Borges R. (2000) Automatic analysis for amperometrical recordings of exocytosis. J. Neurosci. Methods 103, 151-156.
Tillinger A., Sollas A., Serova L. I., Kvetnansky R. and Sabban E. L. (2010) Vesicular monoamine transporters (VMATs) in adrenal chromaffin cells: stress-triggered induction of VMAT2 and expression in epinephrine synthesizing cells. Cell Mol. Neurobiol. 30, 1459-1465.
Tomé A. R., Castro E., Santos R. M. and Rosario L. M. (2007) Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells. BMC Neurosci. 8, 39.
Verberne A. J., Sabetghadam A. and Korim W. S. (2014) Neural pathways that control the glucose counterregulatory response. Front. Neurosci. 8, 38.
Verberne A. J., Korim W. S., Sabetghadam A. and Llewellyn-Smith I. J. (2016) Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes. Br. J. Pharmacol. 173, 1425-1437.
Weihe E., Schafer M. K., Erickson J. D. and Eiden L. E. (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5, 149-164.
Wightman R. M., Dominguez N. and Borges R. (2018) How intravesicular composition affects exocytosis. Pflugers Arch. 470, 135-141.
Yoshimatsu H., Oomura Y., Katafuchi T. and Niijima A. (1987) Effects of hypothalamic stimulation and lesion on adrenal nerve activity. Am. J. Physiol. 253, R418-424.

Auteurs

Ayoze González-Santana (A)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Leandro Castañeyra (L)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Rebeca Baz-Dávila (R)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Judith Estévez-Herrera (J)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Natalia Domínguez (N)

INTEGRARE, Généthon, Inserm, Univ Evry, Université Paris-Saclay, Evry, France.

Iago Méndez-López (I)

Instituto Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain.

J Fernando Padín (JF)

Instituto Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain.
Departamento Ciencias Médicas (Farmacología), Facultad de Medicina, Universidad de Castilla-La Mancha, Ciudad Real, Spain.

Agustín Castañeyra (A)

Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad de La Laguna, Tenerife, Spain.

José-David Machado (JD)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Steven N Ebert (SN)

Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.

Ricardo Borges (R)

Unidad de Farmacología, Facultad de Medicina, Universidad de la Laguna, Tenerife, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH